[1]
|
Parkin, D.M., Bray, F., Ferlay, J., et al. (2000) Estimating the world cancer burden: Globocan. International Journal of Cancer, 94, 153-156. doi:10.1002/ijc.1440
|
[2]
|
Bosch, F.X., Ribes, J., Cléries, R., et al. (2005) Epidemiology of hepatocellular carcinoma. Clinics in Liver Disease, 9, 191-211. doi:10.1016/j.cld.2004.12.009
|
[3]
|
Fassio, E. (2010) Hepatitis C and hepatocellular carcinoma. Annals of Hepatology, 9, 119-122.
|
[4]
|
Capocaccia, R., Sant, M., et al. (2007) Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century. American Journal of Gastroenterology, 102, 1661-1670.
doi:10.1111/j.1572-0241.2007.01337.x
|
[5]
|
El-Serag, H.B. (2007) Epidemiology of hepatocellular carcinoma in USA. Hepatology Research, 37, 88-94.
doi:10.1111/j.1872-034X.2007.00168.x
|
[6]
|
Zhang, B.H., Yang, B.H. and Tang, Z.Y. (2004) Randomized controlled trial of screening for hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology, 130, 417-422. doi:10.1007/s00432-004-0552-0
|
[7]
|
Bolondi, L., Sofia, S., Siringo, S., et al. (2001) Surveillance pro-gramme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: A cost effectiveness analysis. Gut, 48, 251-259.
doi:10.1136/gut.48.2.251
|
[8]
|
Trevisani, F., De Notariis, S., Rapaccini, G., et al. (2002) Semiannual and annual surveillance of cirrhotic patients for hepatocellular carci-noma: Effects on cancer stage and patient survival (Italian experience). American Journal of Gastroenterology, 97, 734-744.
doi:10.1111/j.1572-0241.2002.05557.x
|
[9]
|
Yuen, M.F., Cheng, C.C., Lauder, I.J., et al. (2000) Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology, 31, 330-335. doi:10.1002/hep.510310211
|
[10]
|
Stravitz, R.T., Heuman, D.M., Chand, N., et al. (2008) Surveillance for hepato-cellular carcinoma in patients with cirrhosis improves outcome. American Journal of Medicine, 121, 119-126. doi:10.1016/j.amjmed.2007.09.020
|
[11]
|
Bruix, J. and Sherman, M. (2011) Management of heap-tocellular carcinoma: An update. Hepatology, 53, 1020- 1022. doi:10.1002/hep.24199
|
[12]
|
Arii, S., Sata, M., Sakamoto, M., et al. (2010) Management of hepatocellular carci-noma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009). Hepatology Research, 40, 667-685.
doi:10.1111/j.1872-034X.2010.00673.x
|
[13]
|
Poon, D., Anderson, B.O., Chen, L.T., et al. (2009) Management of hepatocellular carcinoma in Asia: Consensus statement from the Asian Oncology Summit 2009. Lancet Oncology, 10, 1111-1118.
doi:10.1016/S1470-2045(09)70241-4
|
[14]
|
Sarasin, F.P., Giostra, E., Hadengue, A. (1996) Cost- effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis. American Journal of Medicine, 101, 422-434. doi:10.1016/S0002-9343(96)00197-0
|
[15]
|
Arguedas, M.R., Chen, V.K., Eloubeidi, M.A., et al. (2003) Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: A cost-utility analysis. American Journal of Gastroenterology, 98, 679-690.
doi:10.1111/j.1572-0241.2003.07327.x
|
[16]
|
Ganne-Carrié, N., Chastang, C., Chapel, F., et al. (1996) Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis. Hepatology, 23, 1112-1118. doi:10.1002/hep.510230527
|
[17]
|
Degos, F., Christidis, C., Ganne-Carriè, N., et al. (2000) Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut, 47, 131-136.
doi:10.1136/gut.47.1.131
|
[18]
|
Velázquez, R.F., Rodríguez, M., Navascués, C.A., et al. (2003) Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology, 37, 520-527. doi:10.1053/jhep.2003.50093
|
[19]
|
Yuen, M.F., Tanaka, Y., Fong, D.Y., et al. (2009) Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. Journal of Hepatology, 50, 80-88.
doi:10.1016/j.jhep.2008.07.023
|
[20]
|
Kato, H. (1996) Expression and function of squamous cell carcinoma an-tigen. Anticancer Research, 16, 2149- 2153.
|
[21]
|
Pontisso, P., Calabrese, F., Benvegnù, L., et al. (2004) Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma. British Journal of Cancer, 90, 833-837. doi:10.1038/sj.bjc.6601543
|
[22]
|
Guido, M., Roskams, T., Pontisso, P., et al. (2008) Squamous cell carcinoma antigen in human liver carcinogenesis. Journal of Clinical Pathology, 61, 445-447.
doi:10.1136/jcp.2007.051383
|
[23]
|
Benedice, L., Castaldi, F., Marino, M., et al. (2005) Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma. Cancer, 103, 2558-2565. doi:10.1002/cncr.21106
|
[24]
|
Giannelli, G., Fransvea, E., Trerotoli, P., et al. (2007) Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients. Clinica Chimica Acta, 383, 147-152.
doi:10.1016/j.cca.2007.05.014
|
[25]
|
Pontisso, P., Quarta, S., Caberlotto, C., et al. (2006) Pro- gressive increase of SCCA-IgM immune complexes in cirrhotic patients is associated with development of heap- tocellular carcinoma. International Journal of Cancer, 119, 735-740. doi:10.1002/ijc.21908
|
[26]
|
Mazzaferro, V., Regalia, E., Doci, R., et al. (1996) Liver transplantation for the treat-ment of small hepatocellular carcinomas in patients with cirrhosis. New England Jour- nal of Medicine, 334, 693-699.
doi:10.1056/NEJM199603143341104
|
[27]
|
Sangiovanni, A., Del Ninno, E., Fasani, P., et al. (2004) Increased survival of cirrhotic patients with a hepato-cellular carcinoma detected during surveillance. Gastroenterology, 126, 1005-1014.
doi:10.1053/j.gastro.2003.12.049
|
[28]
|
Lin, O.S., Keeffe, E.B., Sanders, G.D., et al. (2004) Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C. Alimentary Pharma-cology and Therapeutics, 19, 1159- 1172. doi:10.1111/j.1365-2036.2004.01963.x
|
[29]
|
Moriyama, M., Matsumura, H., Aoki, H., et al. (2003) Long-term outcome, with monitoring of platelet counts, in patients with chronic hepatitis C and liver cirrhosis after interferon therapy. Intervirology, 46, 296-307.
doi:10.1159/000073209
|
[30]
|
Lok, A.S., Seeff, L.B., Morgan, T.R., et al. (2009) Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology, 136, 138-148.
doi:10.1053/j.gastro.2008.09.014
|